Article
Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia.
Leukemia - 1 Oct 2006
Mesa R A, Tefferi A, Lasho T S, Loegering D, McClure R F, Powell H L, Dai N T, Steensma D P, Kaufmann S H
Abstract excerpt
An activating point mutation in Janus kinase 2 (JAK2 V617F) was recently identified in myelofibrosis with myeloid metaplasia (MMM). To further elucidate the pathogenic significance, we examined the JAK2 mutation burden, phosphorylation of JAK2 substrates and neutrophil apoptotic resistance. Immunoblotting revealed phosphorylation of signal transducer and activator of transcription-3 (STAT3) in all four JAK2 with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.